FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RESUGOSBART
异名/同义词AB-5 (HUMANIZED MONOCLONAL ANTIBODY TARGETED TO SOLUBLE SCLEROSTIN)
GAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV1-18*01 (79,6%) -(IGHD)-IGHJ4*01 (93,3%), CDR-IMGT (8.8.10) (26-33.51-58.97-106)) (1-117)-HOMO SAPIENS IGHG4*01, IGHG4V5 H P10, NG4M(A) CH2 L92 (CH1 (118-215), HINGE 1-12 S10>P (225) (216-227), CH2 L92 (306) (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') ( V-KAPPA (MUS MUSCULUS IGKV6-32*01 (81.9%) -IGKJ1*01 (90,9%)/HOMO SAPIENS IGKV1-39*01 (81.1%) -IGKJ4*01 (91,7%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153),V101 (191) (108'-214')); DIMER (223-223'':226-226'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA
IMMUNOGLOBULIN G4 (225-PROLINE), ANTI-(HUMAN SCLEROSTIN) (HUMAN-MUS MUSCULUS MONOCLONAL HR3012221 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HR3012221 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS SOST (SCLEROSTIN)), MONOCLONAL ANTIBODY
RESUGOSBART
RESUGOSBART [INN]
SHR-1222
SHR-1222 (HUMANIZED MONOCLONAL ANTIBODY TARGETED TO SOLUBLE SCLEROSTIN)
CAS登记号2647412-09-5
物质唯一标识(Unique Ingredient Identifier)54YJA5WXB9
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System